C. de Beaufort

INNODIA Master Protocol for the evaluation of investigational medicinal products in children, adolescents and adults with newly diagnosed type 1 diabetes

E. Bonifacio, M. Knip, D. Dunger, 2022, Trials.

Age-period-cohort modelling of type 1 diabetes incidence rates among children included in the EURODIAB 25-year follow-up study

B. Carstensen, N. Bratina, C. Ionescu-Tirgoviste, 2022, Acta Diabetologica.

Alterations of oral microbiota and impact on the gut microbiome in type 1 diabetes mellitus revealed by integrated multi-omic analyses

P. Bork, A. Heintz‐Buschart, P. May, 2022, Microbiome.

Associations between physical activity, sedentary behavior, and glycemic control in a large cohort of adolescents with type 1 diabetes: the Hvidoere Study Group on Childhood Diabetes

F. Cameron, H. Aanstoot, P. Swift, 2009, Pediatric diabetes.

Seasonal variation in month of diagnosis in children with type 1 diabetes registered in 23 European centers during 1989–2008: little short‐term influence of sunshine hours or average temperature

P. Bingley, A. Green, U. Rothe, 2015, Pediatric diabetes.

Target setting in intensive insulin management is associated with metabolic control: the Hvidoere Childhood Diabetes Study Group Centre Differences Study 2005

M. Phillip, M. Phillip, H. Mortensen, 2009, Pediatric diabetes.

Gut microbiome shifts in people with type 1 diabetes are associated with glycaemic control: an INNODIA study.

T. Vatanen, M. Marcovecchio, C. de Beaufort, 2024, Diabetologia.